Rates of peritonitis among patients on peritoneal dialysis, in episodes per patient-year, varied from 0.40 in Thailand to 0.26 in the United States, a study found.
In a study of dialysis patients with new-onset nonvalvular atrial fibrillation, investigators found a nearly 3-fold higher incidence of fatal or intracranial bleeding among patients who took apixaban compared with those who received no treatment.
Patients on dialysis are at especially high risk of infection and experiencing severe complications of infection. The pandemic may prompt patients and their physicians to consider the benefits of dialyzing at home.
Dialysis facilities have stepped up precautions to protect patients with kidney failure from COVID-19, which can cause severe respiratory illness and death.